Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback Program
Question
Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback Program
Direct answer
A $50 million buyback authorization provides direct equity demand, driving an immediate 7.5% price re-rating in STAA common stock. — bullish pressure on STAA via direct share count reduction via $50M open market repurchase authorization.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-27
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback Program”, revision 1, evidence through 2026-09-27. https://marketontology.com/catalysts/2026-09-27/staar-surgical-rallies-7-5-following-board-approval-of-50-million-buyback-progra-789b61
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| STAA | ▲Bull | 1–5 days | direct share count reduction via $50M open market repurchase authorization | 50 |
Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback Program
A $50 million buyback authorization provides direct equity demand, driving an immediate 7.5% price re-rating in STAA common stock. — bullish pressure on STAA via direct share count reduction via $50M open market repurchase authorization.
Board authorized $50M buyback program, stock surged 7.5%.
- SourceBoard authorized $50M buyback program, stock surged 7.5%.
- TransmissionA $50 million buyback authorization provides direct equity demand, driving an immediate 7.5% price re-rating in STAA common stock.
- SummaryStaar Surgical announced a $50M share repurchase authorization. STAA shares rallied 7.5% in response. Management highlighted cash flow visibility and balance sheet support.
- STAADirect directional exposure
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- STAA closes below pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- STAA price vs. pre-event level
- STAA volume vs. 20-day average
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| STAA | Bullishagreed | 20.51 2026-09-25 | +1.76% | +9.56% | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
Sources
- Why Staar Surgical Stock Soared Today · news · 2026-09-25
Related catalysts
- 2026-09-30Staar Surgical Rallies 8% on Stifel Upgrade and Lens Demand OutlookSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price TargetSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price TargetSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% Following Stifel Upgrade to Buy and $31 TargetSF STAA-1.11%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Buyback ProgramSTAA+9.56%
- 2026-09-27Staar Surgical initiates $50M share repurchase program, lifting stock 7.5%STAA+9.56%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Repurchase ProgramSTAA+9.56%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Repurchase ProgramSTAA+9.56%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.